OPTIPLUG CEMENT RESTRICTOR 4361

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a distributor,health profession report with the FDA on 2016-04-07 for OPTIPLUG CEMENT RESTRICTOR 4361 manufactured by Isotis Orthobiologics, Inc.

Event Text Entries

[42144455] Radiographs alleging the event were received. An acute 2mm abnormality near the distal tip was observed. Another larger unrelated 4-5 mm abnormality laterally about 20mm superior from distal tip was observed. It is unknown which of these are the allegation of osteolysis. There is no current plan for revision, and the patient will continue to be monitored. During the review of the dhr, it was concluded that the product was manufactured on 6/20/2012, inspected and accepted for use and met all specified parameters of the with no associated nonconformance specific to the product issue. No product will be returned as it remains implanted and no further evaluation of the product can be completed at this time. Patient activity level at the time or prior to the event is unknown. Patient's bone quality is good. It is unknown if the patient complied with post-operative care instructions. It is unknown if the concomitant device (hip prosthesis) or bone cement contributed to the event. The complaint database was reviewed and indicated there were other related complaints for osteolysis observation. To date, there are no conclusive findings from this or similar complaint investigations, or from technical or clinical information in the literature that proves or disproves a causal relationship between synplug? & optiplug? Biodegradable cement restrictors or the materials they are manufactured with, and periprosthetic osteolysis (or fractures as a result). There are also no data or findings that would suggest that only some subset of all the products manufactured might be affected. The finding of osteolysis surrounding the distal cement restrictor is unexpected, and undesirable; however, periprosthetic osteolysis in total hip arthroplasty is a well-known problem that is typically a multifactorial process and may be identified through routine radiographic follow-up. Device remains in-situ.
Patient Sequence No: 1, Text Type: N, H10


[42144456] Initial hip replacement (hip arthroplasty) surgery involving a biomet stanmore hip prosthesis, thp cement, and optiplug cement restrictor occurred on (b)(6) 2012. During three year follow up, radiograph depicted osteolysis in patient right leg near the hip stem. Patient is asymptomatic, and currently there is no plan for revision. Surgeon will continue to monitor.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2090010-2016-00003
MDR Report Key5558213
Report SourceDISTRIBUTOR,HEALTH PROFESSION
Date Received2016-04-07
Date of Report2016-03-29
Date of Event2015-12-22
Date Mfgr Received2016-03-29
Device Manufacturer Date2012-06-20
Date Added to Maude2016-04-07
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactPETER PERHACH
Manufacturer Street5770 ARMADA DR.
Manufacturer CityCARLSBAD CA 92008
Manufacturer CountryUS
Manufacturer Postal92008
Manufacturer Phone7602165681
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameOPTIPLUG CEMENT RESTRICTOR
Generic NameCEMENT OBTURATOR
Product CodeLZN
Date Received2016-04-07
Catalog Number4361
Lot Number200781B
Device Expiration Date2016-06-30
OperatorPHYSICIAN
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerISOTIS ORTHOBIOLOGICS, INC
Manufacturer AddressIRVINE CA 96218 US 96218


Patients

Patient NumberTreatmentOutcomeDate
101. Deathisabilit 2016-04-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.